{
  "schema_version": "0.1.0",
  "id": "fda-drug-shortage:rifampin-injection",
  "slug": "rifampin-injection",
  "title": "FDA shortage status: Rifampin Injection",
  "ingredient": "Rifampin Injection",
  "status": "current",
  "source_statuses": [
    "Current",
    "To Be Discontinued"
  ],
  "brand_names": [
    "RIFADIN IV",
    "RIFAMPIN"
  ],
  "therapeutic_categories": [
    "Anti-Infective"
  ],
  "dosage_forms": [
    "Injection"
  ],
  "routes": [
    "INTRAVENOUS"
  ],
  "package_count": 4,
  "packages": [
    {
      "package_ndc": "63323-351-20",
      "product_ndc": "63323-351",
      "company_name": "Fresenius Kabi USA, LLC",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "presentation": "Rifampin, Injection, 600 mg (NDC 63323-351-20)",
      "availability": "Unavailable",
      "dosage_form": "Injection",
      "routes": [
        "INTRAVENOUS"
      ],
      "update_date": "08/04/2026",
      "initial_posting_date": "02/17/2021",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "67457-445-60",
      "product_ndc": "67457-445",
      "company_name": "Mylan Institutional, a Viatris Company",
      "manufacturer_name": "Mylan Institutional LLC",
      "presentation": "Rifampin, Injection, 600 mg (NDC 67457-445-60)",
      "availability": "Unavailable",
      "dosage_form": "Injection",
      "routes": [
        "INTRAVENOUS"
      ],
      "update_date": "08/20/2026",
      "initial_posting_date": "02/17/2021",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "0068-0597-01",
      "product_ndc": "0068-0597",
      "company_name": "Sanofi-Aventis U.S. LLC",
      "manufacturer_name": "Sanofi-Aventis U.S. LLC",
      "presentation": "Rifadin, Injection, 600 mg (NDC 0068-0597-01)",
      "availability": "Unavailable",
      "dosage_form": "Injection",
      "routes": [
        "INTRAVENOUS"
      ],
      "update_date": "06/22/2026",
      "initial_posting_date": "02/17/2021",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "0068-0597-01",
      "product_ndc": "0068-0597",
      "company_name": "Sanofi-Aventis U.S. LLC",
      "manufacturer_name": "Sanofi-Aventis U.S. LLC",
      "presentation": "Rifadin, Injection, 600 mg/10 mL (NDC 0068-0597-01)",
      "availability": null,
      "dosage_form": "Injection",
      "routes": [
        "INTRAVENOUS"
      ],
      "update_date": "04/20/2026",
      "initial_posting_date": "04/20/2026",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    }
  ],
  "availability_counts": {
    "Unavailable": 3
  },
  "initial_posting_date": "02/17/2021",
  "latest_source_update": "08/20/2026",
  "source_updated_at": "2026-08-22",
  "official_url": "https://api.fda.gov/drug/shortages.json",
  "source_name": "U.S. Food and Drug Administration openFDA Drug Shortages",
  "source_license_url": "https://open.fda.gov/license/",
  "retrieved_at": "2026-08-22T15:54:11+00:00",
  "unknowns": {
    "local_availability": "Unknown. FDA status is nationwide and is not local inventory.",
    "clinical_alternatives": "Not provided. CiteFacts does not publish treatment or substitution advice.",
    "resolution_date": "Unknown unless an FDA source row provides an update date."
  },
  "derivations": {
    "status": "current when a grouped FDA row has Current; otherwise it preserves the available FDA Resolved, Discontinuation, or not-current state.",
    "ingredient_page": "Grouped by FDA generic_name, falling back to openFDA.generic_name.",
    "availability_counts": "Count of non-empty FDA package availability values; it is not a claim about local supply."
  }
}